Screener / SEC EDGAR /CIK 0000914156 /10-K filed Feb 27, 2026, compared with Mar 3, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Medical Instruments

UFP Technologies Inc UFPT

Compare with peers Embed
SEC comment letters, last 20 years

2 reviews of UFPT's filings by SEC staff

UPLOAD and CORRESP
Reviews 2 latest letter Aug 5, 2016
Questions asked 5 each answered in the company's own letter
No closing letter 0 reviews without a letter saying the staff completed it

When the SEC's staff reviews a filing, it writes to the company with numbered questions, and the company answers each one in a letter. SEC publishes the exchange once the review is over, at least 20 business days later. A question is not an accusation; most reviews end with the company adding detail to its next filing.

How the reviews went

Every review on EDGAR, from the first staff letter to the letter that closes it

  1. 1. Staff letters 2 UPLOAD
  2. 2. Questions in them 5 numbered comments
  3. 3. Company replies 2 CORRESP
  4. 4. Reviews closed 2 of 2 closing letter

Half the closed reviews took 33 days or less from the first letter to the closing letter.

Form 10-K

2016-08-05 to 2016-09-07 · 2 questions · 1 letter from the SEC, 1 from the company
Review closed 2016-09-07
Financial Statements · Note 20- Related Party Transactions, page F-25
SEC asked (1)
Please tell us why you did not include disclosure regarding the transactions between UFP Technologies, Inc. and Vention Medical, Inc. in your Definitive Proxy Statement considering the board of directors of UFP Technologies, Inc. appointed Daniel Croteau to the board in 2015. See Item 404 of Regulation S-K and Question 130.03 of Compliance and Disclosure Interpretations on Regulation S-K.
UFPT answered
The Company acknowledges the Staff’s comment and submits that disclosure of the transactions (the “Transactions”) between the Company and Vention Medical, Inc. (“Vention”) was not required to be included in the Company’s Definitive Proxy Statement. Mr. Croteau did not have a direct or indirect material interest in the Transactions.

Item 404(a) would only require disclosure of the Transactions in the Company’s Definitive Proxy Statement if Mr. Croteau had a direct or indirect material interest in the Transactions.
Rest of the answer

In addressing the definition of materiality in the context of Item 404(a) of Regulation S-K, the Commission’s 2006 Adopting Release indicates that “…we note that whether a transaction which was not material to the company or the other

100 Hale Street, Newburyport MA 01950 USA | P 978.352.2200 | www.ufpt.com entity involved and which was undertaken in the ordinary course of business of the company and on the same terms that the company offers generally in transactions with persons who are not related persons, are factors that could be taken into consideration when performing the materiality analysis for determining whether disclosure is required under the principle for disclosure.” 1

In advance of the Company’s preparation of its Definitive Proxy Statement, the Company reviewed the circumstances of the Transactions and obtained information about the Transactions from Mr. Croteau. The Company considered various factors in connection with its analysis of whether or not disclosure of the Transactions would be required in the Company’s Definitive Proxy Statement, including the following:

·

The Transactions were made in the ordinary course of business;

The terms of the Transactions, including pricing, were substantially the same terms that the Company generally offers in transactions with persons who are not related persons;

The amount of product that Vention purchased from the Company in 2015 represented less than 0.2% of Vention’s total sales in 2015 and approximately 0.2% of Vention’s total cost of sales in 2015;

The Transactions represented approximately 0.4% of the Company’s total sales in 2015; and

Mr. Croteau received no special compensation or other remuneration from Vention as a result of the Transactions. (Mr. Croteau holds less than 5% of Vention’s shares and any benefit he received from the Transactions as a Vention shareholder was also received by Vention’s other shareholders on a pro rata basis.)

Taking into account the above, the Company determined that Mr. Croteau did not have a direct or indirect material interest in the Transactions and that, therefore, disclosure of the Transactions was not required in the Company’s Definitive Proxy Statement pursuant to Item 404(a) of Regulation S-K. To the extent that the Company and Vention continue to conduct business with each other, the Company will continue to assess whether such transactions would be required to be disclosed pursuant to Item 404(a).

Exhibits

Exhibit 23.01

We note the date of the audit report disclosed in your auditor’s consent does not correspond with the date of the audit report included in your Form 10-K. Please obtain a revised auditor’s consent accordingly.

The Company acknowledges the Staff’s comment and advises the Staff that the discrepancy between the date of the audit reports included in the Form 10-K and the date of the audit reports included in the Company’s auditor’s consent is the result of a scrivener’s error that was present only in the Form 10-K that was filed with the Commission via EDGAR. The text of the audit reports included in the Form 10-K that was filed with the Commission via EDGAR contained the same scrivener’s errors. The original copies of each of the auditor’s consent and the audit reports that the Company received from its auditors reference the correct audit report date. On August 18, 2016, the Company filed an amendment to the Form 10-K that includes copies of the audit reports and auditor’s consent that reflect the correct dates.

1 Executive Compensation Related Person Disclosure, Securities Act Release No. 8732A (Aug. 29, 2006), pages 165-66.

The Company acknowledges that:

the Company is responsible for the adequacy and accuracy of the disclosure in the filing;

staff comments or changes to disclosure in response to staff comments do not foreclose the Commission from taking any action with respect to the filing; and the Company may not assert staff comments as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

We hope that his letter is fully responsive to the Staff’s comments. If you have further questions, please contact me at 978-234-0926.

Read in the reply
In its next report

First report after the company's reply of Aug 18, 2016: 10-Q filed Nov 9, 2016 ↗, against the 10-Q filed May 9, 2016 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Exhibits · Exhibit 23.01
SEC asked (2)
We note the date of the audit report disclosed in your auditor’s consent does not correspond with the date of the audit report included in your Form 10-K. Please obtain a revised auditor’s consent accordingly.
UFPT answered

No numbered answer found in the reply. Read the reply ↗

In its next report

First report after the company's reply of Aug 18, 2016: 10-Q filed Nov 9, 2016 ↗, against the 10-Q filed May 9, 2016 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2016-09-07

Form 10-K for the Fiscal Year Ended December 31, 2011

2012-10-05 to 2012-11-05 · 3 questions · 1 letter from the SEC, 1 from the company
Review closed 2012-11-05
Results discussion (MD&A)Executive paySegments
Incentive Bonus, page 13
SEC asked (1)
We note that in future filings, you will need to expand your executive compensation discussion since, as an accelerated filer, you will no longer be subject to the smaller reporting company scaled disclosure rules. We note that the named executive officers are eligible to receive annual incentive compensation based on the achievement of specific financial and individual goals.
Rest of the question

In future filings, please quantify the financial targets, briefly describe the individual performance goals, disclose the actual level of financial targets and individual performance goals achievement and how the calculation of the incentive compensation was determined for each named executive officer. Refer to Items 402(b)(1)(v) and (2)(v) of Regulation S-K.

UFPT answered
The Company will revise its disclosure as requested by the Staff in its future filings.
Read in the reply
In its next report

First report after the company's reply of Oct 17, 2012: 10-Q filed Nov 9, 2012 ↗, against the 10-Q filed Aug 9, 2012 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Long-Term Incentives, page 13
SEC asked (2)
In future filings, since you will no longer be subject to the smaller reporting company scaled disclosure rules, please discuss the factors considered by the Compensation Committee to determine the amount of long-term incentive stock units to award to each named executive officer.
Rest of the question

Also, in future filings, for each of your named executive officers, please provide a brief description of the financial targets, the actual level of financial target achievement and how the calculation of the actual long-term incentive compensation award was determined.

UFPT answered

No numbered answer found in the reply. Read the reply ↗

In its next report

First report after the company's reply of Oct 17, 2012: 10-Q filed Nov 9, 2012 ↗, against the 10-Q filed Aug 9, 2012 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Results of Operations, page 15
SEC asked (3)
We note from your segment data on page F-27 that operating income for your Packaging segment decreased by 19% from fiscal year 2010 to 2011 despite the 6% increase in sales year over year. Based on your current discussion of your results of operations it is difficult to gain an understanding of the factors that specifically impacted your Packaging segment.
Rest of the question

In future filings please provide your discussion of your results of operations by segment so an investor can better understand the business environment of each segment. Refer to Item 303 of Regulation S-X for guidance.

UFPT answered
The Company hereby acknowledges that:

· the Company is responsible for the adequacy and accuracy of the disclosure in the filing;

· Staff comments or changes to disclosure in response to Staff comments do not foreclose the Commission from taking any action with respect to the filing; and

· the Company may not assert Staff comments as a defense in any proceeding initiated by the Commission or any person under federal securities laws of the United States.
Read in the reply
In its next report

First report after the company's reply of Oct 17, 2012: 10-Q filed Nov 9, 2012 ↗, against the 10-Q filed Aug 9, 2012 ↗.

Tickdelta does not hold the text of both reports, so they are not compared here.

Also in this review: closing letter, 2012-11-05

From the SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), 6 letters filed since 2012-10-05. Questions and answers are matched by their numbers; topics come from words in each question. The reports are compared word for word (same form, before the first SEC letter against the first report after the company's reply). No AI.

Sources

The SEC's correspondence on EDGAR: staff letters (form UPLOAD) and company letters (form CORRESP), matched question by question. No AI.

Also

Filings: the letters in the filing list.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/UFPT/export.csv") into a cell.

Next in Owners and insiders:Insider trades
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.